5344:TSEMARUWA CO., LTD. Analysis
Data as of 2026-05-25 - not real-time
NT$16.10
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Vate Technology is trading at TWD 16.1, which sits just below its 20‑day SMA of 16.38 but comfortably above the 50‑day SMA (15.26) and 200‑day SMA (14.74), suggesting a longer‑term bullish bias. The RSI of 51.3 indicates neutral momentum, while the MACD histogram is negative (-0.11) and the signal line is bearish, pointing to short‑term downside pressure. Volume has been trending lower and the 30‑day volatility is high at 66%, though the stock’s beta is modest (0.25), implying limited market‑wide risk. The Fear & Greed Index reads Extreme Greed, which may be inflating price expectations despite the technical softness.
Fundamentally, the company posted revenue of TWD 340 million with an 11.8% growth rate, yet margins are weak—gross margin is only 5.7% and operating margin is negative at –6.2%. Net profit is negative, resulting in a trailing EPS of –0.39 and a PE ratio of zero, while cash flow remains negative and debt‑to‑equity is high at 7.28. The price‑to‑book of 2.55 exceeds the book value per share (6.32) and there is no dividend, reinforcing concerns that the stock is currently overvalued relative to its earnings and cash‑generation profile.
Fundamentally, the company posted revenue of TWD 340 million with an 11.8% growth rate, yet margins are weak—gross margin is only 5.7% and operating margin is negative at –6.2%. Net profit is negative, resulting in a trailing EPS of –0.39 and a PE ratio of zero, while cash flow remains negative and debt‑to‑equity is high at 7.28. The price‑to‑book of 2.55 exceeds the book value per share (6.32) and there is no dividend, reinforcing concerns that the stock is currently overvalued relative to its earnings and cash‑generation profile.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and signal line
- Price below 20‑day SMA
- Decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue growth of 11.8% despite weak margins
- Longer‑term bullish SMA alignment
- Negative earnings and cash flow
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained negative profitability and cash flow
- High debt‑to‑equity ratio
- Overvalued price relative to book and earnings
Key Metrics & Analysis
Financial Health
Revenue Growth11.80%
Profit Margin-9.15%
ROE-6.01%
ROA-3.73%
Debt/Equity7.28
P/B Ratio2.5
Op. Cash FlowNT$-3725000
Free Cash FlowNT$-12747125
Industry P/E39.5
Technical Analysis
TrendBullish
RSI51.3
SupportNT$15.50
ResistanceNT$17.85
MA 20NT$16.38
MA 50NT$15.26
MA 200NT$14.74
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8
Valuation
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.25
Volatility65.78%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.